Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population

BACKGROUND: The methylation SEPT9 (mSEPT9) appeared to be effective for hepatocellular carcinoma (HCC) detection. However, its performance in high-risk population has not been validated. We designed a pilot study and aimed to investigate the performance of mSEPT9, AFP, PIVKA-II and their combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Kepu, Dai, Leiyang, Zhao, Yingpeng, Li, Laibang, Li, Wang, Zhang, Xibing, Su, Qiuming, Wu, Ruichao, Jiang, Yizhou, Chen, Yonglin, Ran, Jianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388499/
https://www.ncbi.nlm.nih.gov/pubmed/37525116
http://dx.doi.org/10.1186/s12876-023-02900-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388499/
https://www.ncbi.nlm.nih.gov/pubmed/37525116
http://dx.doi.org/10.1186/s12876-023-02900-6

Ejemplares similares